| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A ubiquitin ligase toggles red cell differentiation
|
Verheul, Thijs C.J.
|
|
|
137 |
2 |
p. 143-144
|
artikel
|
| 2 |
Cerebrospinal fluid with unusual natural killer cell population
|
Al Moosawi, Muntadhar
|
|
|
137 |
2 |
p. 281
|
artikel
|
| 3 |
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
|
Collins, Paul J.
|
|
|
137 |
2 |
p. 203-215
|
artikel
|
| 4 |
Composite mantle cell lymphoma and small lymphocytic lymphoma in a lymph node
|
Mass, Jirong
|
|
|
137 |
2 |
p. 282
|
artikel
|
| 5 |
EBV and myeloid-derived suppressor cells
|
Sinha, Debottam
|
|
|
137 |
2 |
p. 148-150
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
137 |
2 |
p. i
|
artikel
|
| 7 |
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines
|
Pleyer, Christopher
|
|
|
137 |
2 |
p. 185-189
|
artikel
|
| 8 |
Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets
|
Whyte, Claire S.
|
|
|
137 |
2 |
p. 248-257
|
artikel
|
| 9 |
FBXO11-mediated proteolysis of BAHD1 relieves PRC2-dependent transcriptional repression in erythropoiesis
|
Xu, Peng
|
|
|
137 |
2 |
p. 155-167
|
artikel
|
| 10 |
Heme control to major B (cell): are you listening?
|
Pirenne, France
|
|
|
137 |
2 |
p. 153-154
|
artikel
|
| 11 |
Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease
|
Pal, Mouli
|
|
|
137 |
2 |
p. 269-280
|
artikel
|
| 12 |
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
|
Greiner, Georg
|
|
|
137 |
2 |
p. 238-247
|
artikel
|
| 13 |
How I manage cyclic thrombocytopenia
|
Kyrle, Paul A.
|
|
|
137 |
2 |
p. 178-184
|
artikel
|
| 14 |
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
|
Gooding, Sarah
|
|
|
137 |
2 |
p. 232-237
|
artikel
|
| 15 |
Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia
|
Teachey, David T.
|
|
|
137 |
2 |
p. 168-177
|
artikel
|
| 16 |
Remodel your way to fetal hematopoiesis
|
Tamplin, Owen J.
|
|
|
137 |
2 |
p. 146-148
|
artikel
|
| 17 |
Smarca5-mediated epigenetic programming facilitates fetal HSPC development in vertebrates
|
Ding, Yanyan
|
|
|
137 |
2 |
p. 190-202
|
artikel
|
| 18 |
Tissue factor pathway inhibitor is required for cerebrovascular development in mice
|
Maroney, Susan A.
|
|
|
137 |
2 |
p. 258-268
|
artikel
|
| 19 |
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
|
Ioannou, Nikolaos
|
|
|
137 |
2 |
p. 216-231
|
artikel
|
| 20 |
Triggering T-cell activity in CLL
|
Mertens, Daniel
|
|
|
137 |
2 |
p. 150-151
|
artikel
|
| 21 |
Vaccinations in CLL: implications for COVID-19
|
Shadman, Mazyar
|
|
|
137 |
2 |
p. 144-146
|
artikel
|
| 22 |
What your HαT says about you
|
Gotlib, Jason
|
|
|
137 |
2 |
p. 151-153
|
artikel
|
Tijdschrift beschrijving